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The radiation dose involved in any medical imaging modality that uses ionizing radiation needs to be
well understood by the medical physics and clinical community. This is especially true of screening
modalities. Digital breast tomosynthesis (DBT) has recently been introduced into the clinic and is
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being used for screening for breast cancer in the general population. Therefore, it is important that
the medical physics community have the required information to be able to understand, estimate, and
communicate the radiation dose levels involved in breast tomosynthesis imaging. For this purpose,
the American Association of Physicists in Medicine Task Group 223 on Dosimetry in Tomosynthesis
Imaging has prepared this report that discusses dosimetry in breast imaging in general, and describes
a methodology and provides the data necessary to estimate mean breast glandular dose from a to-
mosynthesis acquisition. In an effort to maximize familiarity with the procedures and data provided
in this Report, the methodology to perform the dose estimation in DBT is based as much as possi-
ble on that used in mammography dose estimation. © 2014 American Association of Physicists in
Medicine. [http://dx.doi.org/10.1118/1.4892600]
Key words: breast tomosynthesis, dosimetry, Monte Carlo, mammography, breast cancer, mean glan-
dular dose, conversion factor, relative glandular dose
1. INTRODUCTION
Radiation dosimetry in x-ray based breast imaging is con-
cerned with the estimation of the dose to only the glandular
tissues present in the imaged breast, since there is minimal
risk of cancer development in the adipose tissues.1 Therefore,
the numerous studies reported on radiation dosimetry from
mammography have used the glandular dose as the primary
dose metric.2–7 The dose estimations in these studies were
performed using Monte Carlo simulations and the approxima-
tion of the imaged breast as composed of a homogeneous mix-
ture of adipose and glandular tissue, with varying amounts of
each tissue in the mixture. This homogeneity approximation is
necessary due to two factors: (i) The computational complex-
ity, especially in the early days, of simulating complex hetero-
geneous patterns of glandular/adipose tissue distribution and
(ii) the natural variability of the glandular parenchyma in pa-
tients, making it impossible to simulate the infinite number of
possible tissue distributions in human breasts. The homogene-
ity approximation, along with the use of a single dose value
for the entire breast, gives rise to the term mean glandular
dose, the metric actually estimated in mammography dosime-
try studies. Although this metric does not represent an indi-
vidual patient’s dose and has the potential to result in an over-
estimation of actual patient glandular dose,8 this metric does
provide a method to compare the dosimetric consequences of
different imaging technologies, acquisition techniques, and/or
protocols. Finally, to relate the mean glandular dose estimate
to the exposure level used for the study in question, the metric
reported by mammography dosimetry studies is the normal-
ized mean glandular dose (DgN), in which the mean glandular
dose is normalized by a “reference” exposure or air kerma re-
sulting from the imaging technique, at a pre-established point
or area of reference. Therefore, the units of DgN are dose per
exposure (typically mGy/R) or dose per air kerma (typically
mGy/mGy air kerma). Traditionally, the “reference” exposure
has been defined as the exposure at the x-ray entrance surface
of the breast under the compression paddle, denoted the en-
trance skin exposure (ESE). Due to this definition of the “ref-
erence” exposure, the exposure measured at one point in the
x-ray beam (normally a few cm above the detector surface)
is then adjusted by the inverse-square distance relationship to
compute the ESE for breasts of varying thickness.
2. DOSIMETRY IN BREAST TOMOSYNTHESIS
Radiation dosimetry in breast tomosynthesis has, in gen-
eral, been studied using the same methods as those used in
mammography.9–12 However, in tomosynthesis the possible
variation in dosimetry due to the change in geometry dur-
ing acquisition must be addressed. To determine the impact
that the change in position of the x-ray tube (possibly accom-
panied by a rotation of the detector in some tomosynthesis
systems13) has on dosimetry, including the change in distance
between the tube and the entrance surface of the breast, the
term relative glandular dose (RGD) has been introduced.9, 10
The RGD describes the change in the mean glandular dose
between a zero-degree projection acquisition (equivalent to a
mammography acquisition) and a projection acquisition at a
non-zero angle using exactly the same imaging technique (tar-
get, filter, tube voltage, and tube current-exposure time prod-
uct), therefore
RGD (α) = DgN (α)
DgN (0◦)
. (1)
The RGD has been determined to be a function only of
projection angle and breast size and thickness, being largely
independent of x-ray spectrum and breast glandular fraction.9
RGD can be used in combination with DgN values for mam-
mography (DgNMAMMO). When constant tube voltage and
tube current-exposure time product are used for all projec-
tions, the following equation can be used for DgNTOMO:
DgNTOMO = DgNMAMMO
⎛
⎜⎜⎝
αMAX∑
α=αMIN
RGD (α)
Nα
⎞
⎟⎟⎠ , (2)
where DgNTOMO is the normalized glandular dose for a com-
plete tomosynthesis acquisition, DgNMAMMO is the normal-
ized glandular dose for a mammography acquisition, RGD(α)
is the relative glandular dose at each projection angle α in-
cluded in the tomosynthesis acquisition, and Nα is the to-
tal number of projections in the tomosynthesis acquisitions.
For specific breast tomosynthesis systems with a fixed num-
ber of projections at fixed angular locations, Eq. (2) can be
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simplified to the following:
DgNTOMO = DgNMAMMO × RGD, (3)
where RGD is the mean RGD value for the complete breast
tomosynthesis acquisition.
If an advanced acquisition protocol is used in which the
tube current-exposure time product is varied among the pro-
jections, Eq. (2) needs to be modified, resulting in
DgNTOMO = DgNMAMMO
⎛
⎜⎜⎝
αMAX∑
α=αMIN
mAsα
mAs0 RGD (α)
Nα
⎞
⎟⎟⎠ , (4)
where mAsα is the tube current-exposure time product used
at projection angle α and mAs0 is the tube current-exposure
time product for the 0◦ projection.
In this report we provide RGD values for a generic system
and the RGD and RGD values for five vendor-specific system
designs. Given the low sensitivity of RGD to geometric vari-
ations, such as the vertical location of the center of rotation
of the x-ray tube, we believe that the RGD values provided
here for a generic system can be used for future commercial
tomosynthesis systems. However, depending on the need for
new values, the Tomosynthesis Subcommittee of the Ameri-
can Association of Physicists in Medicine might publish new
system-specific RGD values in the future.
The DgNMAMMO data required for computation of
DgNTOMO in combination with the RGD data provided in
this report can be found in either of the previously published
studies by Wu et al. for x-ray tubes with molybdenum
and rhodium targets.4, 5 For other x-ray spectra or breast
thicknesses not included in those publications, other sources
of DgNMAMMO values are available, in both polyenergetic and
monoenergetic form.3, 6, 7, 9–12, 14, 15 Additional DgNMAMMO
values might be published in the future by the Mammography
Subcommittee of the American Association of Physicists in
Medicine.
To estimate the mean glandular dose for a breast tomosyn-
thesis study using the information in this report and the mam-
mography dosimetry data, the “reference” air kerma mea-
surement should, in general, be performed as per the 1999
American College of Radiology (ACR) Quality Control
Manual. However, due to the time-varying geometry dur-
ing tomosynthesis acquisition (in particular, the oblique pro-
jection views), the following changes in measurement are
needed: (i) one acquisition should be performed with the ACR
phantom in its usual location and the technique selected by the
automatic exposure control recorded; (ii) a second acquisi-
tion should be performed, using the previously recorded tech-
nique, without the phantom in place but with the dosimeter, in
integrating mode, (ionization chamber or solid-state) placed
at the midline of the detector in the chest wall direction (4 cm
anterior to the chest wall edge) and at the typical measurement
height above the detector, with the breast compression paddle
placed at its maximum distance from the detector and a lead
shield covering the detector. For full-field systems (i.e., ex-
cluding the Philips MicroDose and any other future slot-scan
systems), if possible, the measurement should be performed
in the acquisition mode that allows for the tomosynthesis tar-
get/filter combination to be used but with all exposures per-
formed with the x-ray tube at the mammography (0◦) position.
If a static mode is not available, care should be taken to verify
that the response of the dosimeter, especially if a solid-state
dosimeter is used, is independent of the angle of incidence
of the x-ray beam for the sweep angle studied. The smallest
field of view that includes the entire sensitive volume of the
dosimeter should be used, which might require an additional
beam-limiting aperture in the raised paddle. In slot scan sys-
tems, the reduction of the field of view to minimize scatter
contribution from the compression paddle is not needed due
to the reduced x-ray beam area in this type of system.
The process to determine breast mean glandular dose from
the data provided in this report is summarized in Fig. 1.
3. METHODS
3.A. Breast model
In this report we replicate the mammography model used
by Wu et al.4, 5 Therefore, the breast was modeled in the
cranio-caudal (CC) view as half an elliptical cylinder, with
an 8 cm chest-wall to nipple distance and an 18 cm length
along the chest-wall. The breast skin thickness was 4 mm,
and the remaining breast tissue was composed of a homoge-
neous mixture of adipose and glandular tissue, with various
weight fractions of 1%, 25%, 50%, 75%, and 100% glandular
tissue. The chemical compositions of the three breast tissues
were defined by Hammerstein et al.1 The compressed breast
thickness was varied from 2 to 9 cm, in 1 cm steps. Although
the breast model used by Wu et al.4, 5 includes thicknesses
only from 3 to 8 cm, 2 and 9 cm breast thicknesses are in-
cluded in this report due to their prevalence in the clinic and
the availability of mammography dose data for this thickness
range from other sources, such as Boone.7
3.B. System model
All simulation details attempted to follow the Wu et al.
model.4, 5 Specifically, the x-ray source was modeled as a
point source that emits x rays only within the limits of the sim-
ulated detector. The x rays emitted were randomly sampled
from a probability distribution function based on the spec-
tral models provided by Boone et al.,16 considering the cor-
responding added tube filtration and filtration due to a 2 mm
thick polymethyl methacrylate breast compression paddle, a
1 mm thick Be window, a mirror [defined as a very thin layer
of BoPET (Biaxially oriented polyethylene terephthalate) and
aluminum] typically placed in the x-ray beam path for align-
ment of the light field, and the air between the x-ray source
and the breast volume.
Figure 2 shows a diagram of a “standard” tomosynthesis
system, including the x-ray source, breast compression pad-
dle, breast support plate, compressed breast, and digital detec-
tor. In some systems, the detector rotates during acquisition,
while in others it remains stationary. This diagram shows the
simplified version of the geometry used for the simulations in
this report, using the system parameters as listed in Tables I
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FIG. 1. Summary of process to determine breast mean glandular dose for
a tomosynthesis acquisition from the data provided in this report. (*) Use a
phantom such as the ACR accreditation phantom and record the technique
determined by the AEC of the system or decide the technique of interest.
(†) For the Philips slot scanning system, skip step 7 and use Eq. (6) and
Table VIII.
and II. The geometry of the Philips MicroDose system is sub-
stantially different from that shown here, and it is discussed
in Sec. 3.F.
3.C. Monte Carlo simulations
We used a previously validated9 Monte Carlo simulation
based on version 9.6 patch 02 of the Geant4 toolkit,17, 18 using
FIG. 2. Diagram of a typical breast tomosynthesis system. The x-ray source
rotates around the compressed breast while the system acquires a limited
number of projection images. Some system designs include detector rotation
while in others the detector remains stationary.
the Livermore physics model for the electromagnetic interac-
tions. During the simulation of each projection acquisition,
106 x rays were simulated from their emission by the x-ray
source until their complete absorption or exit from the sim-
ulation limits. This number of x rays resulted in a statistical
uncertainty lower than 0.6% for all simulations. The x rays
could undergo photoelectric effect and Rayleigh and Comp-
ton scatter, according to the physics models used by the sim-
ulation. For every energy depositing event occurring within
the adipose-glandular mixture breast tissue, the amount of en-
ergy deposited was recorded and weighted so as to obtain the
energy deposited only in the glandular tissue portion of the
mixture, using the equation:6
EG,DEP =
fg
(
μen
ρ
)
g
fg
(
μen
ρ
)
g
+ (1 − fg)
(
μen
ρ
)
a
EDEP, (5)
where EG,DEP is the energy deposited in the glandular tissue,
EDEP is the total energy deposited during the interaction in
the breast tissue, fg is the glandular fraction and (μen/ρ)a and
(μen/ρ)g are the mass energy absorption coefficients of adi-
pose and glandular tissue, respectively. To compute RGD(α),
the total EG,DEP for the simulated projection at angle α was
divided by the total EG,DEP resulting from the simulation of
the zero degree projection.
Because it has been found that RGD does not vary
substantially with x-ray spectrum and breast composition,9
the RGD values reported here are the mean RGD values
resulting from a range of these factors and are a function of
breast thickness only. As mentioned, the range of breast com-
positions included is 1%–100% glandular density, while the
range of x-ray spectra included in the simulations is specified
in the tables describing the simulation parameters.
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TABLE I. Generic tomosynthesis system specifications used to determine
RGD values.
Imager size (cm) 24 × 30
Source to detector distance (cm) 66.0
Detector to x-ray tube center of rotation distance (cm) 0.0
Air gap (cm) 2.2
Number of projections 31
Angular range (deg) ±30
Detector rotation No
Target/filter materials W/50 μm Rh
Tube voltage (kVp) 23–39
3.D. Simulation parameters for generic breast
tomosynthesis system model
Table I provides the specifications used to compute the
RGD values for a generic theoretical breast tomosynthesis
system. These parameters were chosen to reflect typical or
average values found in commercial or prototype systems cur-
rently in existence. It should be noted that throughout this re-
port, all projection angle information, including the angular
range, is provided relative to the center of rotation, which is
not necessarily located at the detector entrance surface.
3.E. Simulation parameters for specific breast
tomosynthesis system models
Table II provides the specifications assumed to compute
the RGD values for the specific breast tomosynthesis systems
included in this report, based on the currently available public
knowledge.13
3.F. Philips MicroDose tomosynthesis
prototype system
The Philips MicroDose tomosynthesis prototype system is
a scanning multislit full-field digital mammography system,
FIG. 3. Diagram of the Philips MicroDose tomosynthesis prototype system.
(Left) An x-ray tube, a multislit precollimator, and a photon-counting detec-
tor are mounted on a scan arm, rotating about a point below the detector.
(Right) The x-ray beam is collimated before entering the breast to match the
21 photon counting line detectors.
which consists of a mammography x-ray tube, a multislit pre-
collimator, and an image receptor, all mounted on a rigid scan
arm (see Fig. 3). To acquire an image, the scan arm is rotated
about a point below the detector so that the tube movement
describes an arc above the object. Hence, each point in the
object is viewed from a range of source-detector angles by
different detector segments as the detector scans the object.
This angular range (tomo angle) of 11◦ is determined most
importantly by the width of the detector (50 mm or 4.6◦ from
the tube focus point of view) and also by the angular range
of the scan arm rotation (±15◦). A large number of photon
counting detector elements are read out continuously during a
single scanning motion.
TABLE II. Breast tomosynthesis system specifications used in this report (Ref. 13). This information is believed accurate as of September 20, 2013. Modifica-
tions in the specifications of any of these systems may have an impact on the accuracy of the results provided in this report.
Siemens
GE Hologic IMS Giotto Philips MAMMOMAT
SenoClaire Selenia Dimensions TOMO MicroDose Inspiration
Imager size (cm) 24 × 30 24 × 29 24 × 30 21 lines × 24 cm 24 × 30
Source to detector distance (cm) 66.0 70.0 68.0 66.0 65.5
Detector to x-ray tube center of rotation distance (cm) 4.0 0.0 2.0 −40.0 4.7
Air gap (cm) 2.2 2.5 2.2 0.4−2.4 1.7
Number of projections 9 15 13 (see text) 25
Angular range (deg) ±12.5 ±7.5a ±20 11 (see text) ±23b
Detector rotation No Yes No Continuous slit scan No
Target/filter material Mo/Mo, Mo/Rh, and Rh/Rh W/Al W/Rh and W/Ag W/Al W/Rh
Filter material/thickness Mo: 0.03 mm 0.7 mm Al Rh: 0.05 mm 0.5 mm Al 0.05 mm Rh
Rh: 0.025 mm Ag: 0.05 mm
Tube voltage (kVp) Mo/Mo: 24–30 26–40 W/Rh: 23–35 26–38 23–35
Mo/Rh: 26–32 W/Ag: 23–35
Rh/Rh: 26–40
aThe Hologic Selenia Dimensions allows for an alternative acquisition mode with an angular range of ±15◦. This mode, however, is currently not approved for clinical
use. Therefore the dosimetric data for this mode are provided in the Appendix.
bThe x-ray tube rotation has a ±25◦ range, but the projections are acquired within the central ±23◦ of the total range of motion.
Medical Physics, Vol. 41, No. 9, September 2014
091501-6 Sechopoulos et al.: Breast Tomosynthesis Radiation Dosimetry: Task Group 223 Report 091501-6
Given the differences in the acquisition geometry of the
Philips system compared to the other tomosynthesis systems,
it is necessary to use a different dosimetry method to estimate
the glandular dose for a complete breast tomosynthesis acqui-
sition. Specifically for this system, given a measurement of
the “reference” air kerma (AKREF), the glandular dose (Dg)
can be estimated using the equation:
Dg,TOMO = DgNTOMO × AKREF, (6)
where values for DgNTOMO are provided in this report and the
AKREF should be measured as described in Sec. 2.
As opposed to the simulations for the other tomosynthesis
systems, the Monte Carlo simulations for the Philips scanning
system used a random projection angle for each simulated x-
ray, within the angular range of the scan arm of the system.
Upon selection of the source position for each x-ray, the pos-
sible emission direction of each was randomly selected to be
within the angle subtended by the detector segments in their
corresponding position. The interactions and processes that
each x-ray underwent after emission were simulated in the
same manner as for the other tomosynthesis systems, yielding
the average breast glandular dose for each scan. A second sim-
ulation for each imaging condition was performed, with the
breast volume replaced by a surface representing the entrance
of the ion chamber, yielding the “reference” air kerma used
for each simulation. The normalized glandular dose values
were obtained by normalizing the simulated average breast
glandular dose by the simulated “reference” air kerma. The
simulations to estimate the former involved 106 x rays, while
for the latter 50 × 106 x rays were simulated.
3.G. Validation of Monte Carlo simulations
The conditions simulated by Wu et al. were replicated as
closely as possible and the results are compared to those in-
cluded in that publication.4 For this comparison, the com-
pressed breast thickness ranged from 3 to 8 cm in steps of
1 cm, and the x-ray spectra were specified as those emitted
by a molybdenum anode with an added 0.3 mm thick molyb-
denum filter, a compression paddle of approximately 2 mm
and with tube voltages varying from 23 to 35 kVp in steps
of 4 kVp. For each tube voltage target/filter combination, the
thickness of the compression paddle hardening the x-ray spec-
trum was varied so that the first half-value layer of the spec-
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FIG. 4. Comparison of the normalized glandular dose for varying com-
pressed breast thicknesses and x-ray spectra as estimated by the simulation
used in this report and that published by Wu et al. (Ref. 4).
trum incident upon the breast matched one of the first half-
value layers of the corresponding spectra used by Wu et al.
4. RESULTS
4.A. Validation of Monte Carlo simulations
Figure 4 compares the normalized mean glandular dose re-
ported by Wu et al.4 to that estimated by the Monte Carlo
simulation used in this report. As can be seen, the results are
very similar, with the slope of the linear fit having a value of
1.0084 (95% confidence interval: 1.0012–1.0157) and an off-
set value of 2.4591 millirad/R (95% CI: 1.3076–3.6107 mil-
lirad/R). Therefore, the simulation used in this report can be
considered validated against previously published data.
4.B. Generic breast tomosynthesis system
Table III provides the resulting RGD values for the generic
breast tomosynthesis system described in Table I. When cal-
culating DgNTOMO for a specific system, the appropriate RGD
value(s) for the specific angles used by the system must be
looked-up and/or interpolated from the table, and, together
with the total number of projections and the value for the cor-
responding DgNMAMMO from Wu et al., be used as inputs to
Eq. (1). If RGD values for angles larger than 30◦ are needed,
these can be extrapolated from the data provided, as the RGD
TABLE III. RGD values for the generic tomosynthesis system.
Angle (deg)Thickness
(cm) 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
2 1.000 1.000 0.999 0.996 0.993 0.990 0.982 0.976 0.968 0.959 0.950 0.938 0.927 0.913 0.899 0.883
3 1.000 0.999 0.999 0.994 0.990 0.983 0.977 0.968 0.959 0.947 0.935 0.922 0.907 0.891 0.874 0.855
4 1.000 1.000 0.997 0.993 0.987 0.982 0.974 0.963 0.953 0.939 0.926 0.910 0.894 0.877 0.859 0.840
5 1.000 0.998 0.995 0.993 0.987 0.979 0.969 0.959 0.945 0.932 0.917 0.902 0.884 0.866 0.848 0.828
6 1.000 0.999 0.995 0.991 0.983 0.976 0.965 0.954 0.940 0.927 0.911 0.895 0.878 0.860 0.842 0.823
7 1.000 0.998 0.996 0.991 0.983 0.975 0.964 0.950 0.936 0.923 0.907 0.891 0.874 0.857 0.839 0.817
8 1.000 1.000 0.997 0.990 0.983 0.974 0.961 0.949 0.934 0.920 0.905 0.889 0.872 0.852 0.831 0.805
9 1.000 0.998 0.994 0.989 0.981 0.971 0.958 0.945 0.931 0.916 0.901 0.884 0.863 0.841 0.817 0.790
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TABLE IV. RGD and RGD values for the GE SenoClaire tomosynthesis system.
Angle (deg)Thickness
(cm) 0 3.125 6.25 9.375 12.5 RGD
2 1.000 0.999 0.996 0.990 0.982 0.994
3 1.000 1.000 0.994 0.988 0.979 0.992
4 1.000 0.999 0.993 0.986 0.974 0.990
5 1.000 0.999 0.992 0.983 0.970 0.989
6 1.000 0.999 0.993 0.983 0.969 0.989
7 1.000 0.997 0.991 0.980 0.966 0.987
8 1.000 0.998 0.991 0.979 0.963 0.986
9 1.000 0.998 0.991 0.978 0.961 0.986
values for each thickness form smooth curves. The DgNTOMO
value (Eq. (3)) can then be multiplied by the entrance skin ex-
posure to obtain the glandular dose from one tomosynthesis
acquisition, as per the usual method used for mammography
dose estimation. Because this report and the Wu et al. mam-
mography dose data include only the CC view, resulting in a
symmetric geometry acquisition about the midline of the de-
tector, only the results for the positive projection angles are
reported here.
4.C. Specific commercial and prototype breast
tomosynthesis systems
Tables IV–VII provide the individual RGD and RGD val-
ues for the specific breast tomosynthesis systems included
in this report, except for the Philips MicroDose system. Al-
though RGD is sufficient to determine DgNTOMO for a to-
mosynthesis examination, the individual RGD values are
needed if more advanced tomosynthesis acquisitions are used,
such as protocols with varying tube current-exposure time
product per projection angle. It should be noted that the RGD
provided is not just the mean of the RGD values listed in the
tables, but the mean for the complete acquisition set, so the
non-zero projections are included twice in the calculation of
RGD, assuming a symmetric acquisition sweep.
Figure 5 shows a graph of the RGD values for the four
commercial systems and the generic system for a 5 cm thick
breast. It can be seen that all systems display similar trends in
RGD with projection angle.
FIG. 5. RGD(α) values vs projection angle for a 5 cm thick compressed
breast for the four commercial full field tomosynthesis systems and the
generic system description included in this report.
Table VIII provides the DgNTOMO values for the Philips
MicroDose tomosynthesis prototype system to be used with
the measured “reference” air kerma values to obtain the esti-
mate of the glandular dose, using Eq. (6).
5. DISCUSSION
This report provides the methodology and data neces-
sary to estimate breast glandular dose for breast tomosynthe-
sis imaging as an addition to the established mammography
methodology. We have replicated the imaging model devel-
TABLE V. RGD and RGD values for the Hologic Selenia Dimensions tomosynthesis system.
Angle (deg)Thickness
(cm) 0.00 1.07 2.14 3.21 4.29 5.36 6.43 7.50 RGD
2 1.000 1.000 0.998 0.997 0.997 0.996 0.996 0.994 0.997
3 1.000 0.999 1.000 0.999 0.999 0.997 0.994 0.993 0.998
4 1.000 1.000 1.000 1.000 0.998 0.997 0.995 0.991 0.998
5 1.000 0.998 0.999 0.999 0.995 0.994 0.991 0.988 0.996
6 1.000 0.999 1.000 0.997 0.996 0.994 0.992 0.988 0.996
7 1.000 1.000 0.998 0.998 0.996 0.994 0.990 0.987 0.995
8 1.000 1.000 1.000 0.998 0.997 0.995 0.990 0.987 0.996
9 1.000 1.000 1.000 0.997 0.995 0.993 0.989 0.985 0.995
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TABLE VI. RGD and RGD values for the IMS Giotto TOMO tomosynthesis system.
Angle (deg)Thickness
(cm) 0.000 3.333 6.667 10.000 13.333 16.667 20.000 RGD
2 1.000 0.998 0.996 0.988 0.980 0.969 0.955 0.984
3 1.000 0.999 0.994 0.987 0.975 0.960 0.943 0.980
4 1.000 0.998 0.993 0.983 0.971 0.954 0.935 0.976
5 1.000 0.999 0.991 0.981 0.967 0.948 0.926 0.973
6 1.000 0.998 0.989 0.980 0.963 0.942 0.920 0.970
7 1.000 0.998 0.990 0.978 0.961 0.940 0.918 0.969
8 1.000 0.998 0.990 0.976 0.958 0.937 0.915 0.968
9 1.000 0.996 0.988 0.974 0.954 0.934 0.911 0.965
oped by Wu et al. to minimize the differences when estimat-
ing mean glandular dose from tomosynthesis compared to that
from mammography.
For consistency, the single breast size specified by Wu
et al. was considered in this report. RGD values for other
breast sizes can be calculated from fits for both the CC and
MLO views published by Sechopoulos et al.9 In that work,
the breast model used was different from that defined by Wu
et al., with the main differences being: (i) inclusion of the
compression paddle and breast support and cover plates in
the simulations, resulting in the inclusion of their contribu-
tion to scatter dose, (ii) inclusion of the heel effect, (iii) the
breast modeled with curved edges, and (iv) inclusion of air.
However, a comparison of the RGD values provided in this
report with those reported by Sechopoulos et al.9 for the CC
view, showed that the average difference in corresponding
RGD is 1.2%, with a range of −6.4% to +0.3%. Therefore, as
stated above, the fit equations for RGD provided by that work
can be used if other breast sizes or other characteristics are
needed.
As can be seen from the tables of dosimetry data for the
specific breast tomosynthesis systems included in this report,
the values of RGD do not deviate substantially from unity.
Therefore, if the dose estimation required is for that of a
“standard” tomosynthesis acquisition, i.e., constant tube
current-exposure time product for all projections and symmet-
ric acquisition angles about 0◦, then, to within a 5% error, the
value of RGD can be assumed to be unity and the normalized
glandular dose values for mammography can be used to esti-
mate the glandular dose for a tomosynthesis acquisition. If a
more accurate estimation is needed, or if the acquisition pro-
tocol incorporates either varying tube current-exposure time
products for different projection angles and/or non-symmetric
projection angles about 0◦, then the values provided in these
tables for RGD(α) and RGD should be used.
As can be seen from Fig. 5, the RGD(α) for the differ-
ent systems show the same trends in terms of variation with
projection angle. Some difference can be seen, most proba-
bly introduced by the difference in position of the center of
rotation among the systems, which causes a different varia-
tion in the source-to-entrance surface distance with projection
angle.
The presented dosimetry model has some limitations. In
the first place, and most importantly, this model does not
estimate patient-specific dose values. Several enhancements
would need to be made for patient-specific estimates, chief
among them the use of the actual distribution of glandu-
lar tissue within the breast, as opposed to the homogeneous
tissue mixture, which has been shown to introduce large
uncertainties.8, 19 However, this would make the use of pre-
calculated tabular values impossible, since there are infinite
possibilities of glandular tissue distribution. Other enhance-
ments to the model would involve the use of a more realistic
breast shape, the inclusion of the mediolateral oblique (MLO)
view, and the use of a more realistic x-ray field distribution,
including the heel effect. However, for consistency with the
existing mammography model, the assumptions and simplifi-
cations used by Wu et al. were maintained.
TABLE VII. RGD and RGD values for the Siemens MAMMOMAT Inspiration tomosynthesis system.
Angle (deg)Thickness
(cm) 0.000 1.917 3.833 5.750 7.667 9.584 11.500 13.417 15.334 17.250 19.167 21.084 23.000 RGD
2 1.000 1.000 1.000 0.997 0.996 0.992 0.988 0.986 0.980 0.976 0.970 0.963 0.956 0.985
3 1.000 1.000 1.000 0.998 0.996 0.993 0.986 0.983 0.976 0.969 0.961 0.950 0.940 0.981
4 1.000 1.000 0.999 0.997 0.994 0.988 0.984 0.977 0.970 0.960 0.951 0.941 0.930 0.976
5 1.000 1.000 1.000 0.996 0.993 0.986 0.980 0.972 0.965 0.955 0.945 0.933 0.920 0.973
6 1.000 1.000 0.997 0.994 0.990 0.984 0.978 0.969 0.960 0.950 0.939 0.927 0.914 0.969
7 1.000 0.998 0.995 0.993 0.989 0.983 0.974 0.966 0.956 0.945 0.934 0.922 0.909 0.966
8 1.000 0.998 0.997 0.993 0.988 0.981 0.973 0.963 0.955 0.942 0.931 0.918 0.907 0.965
9 1.000 1.000 0.998 0.994 0.989 0.981 0.974 0.964 0.951 0.941 0.929 0.917 0.905 0.965
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TABLE VIII. DgNTOMO values (mGy/mGy air kerma) for the Philips MicroDose tomosynthesis system for varying compressed breast thickness (2–9 cm), tube
voltage (26–38 kVp) and glandular fraction (1%–100%).
Glandular fraction (%)
2 cm thick 1 25 50 75 100
26 kVp 0.527 0.501 0.475 0.448 0.424
29 kVp 0.533 0.510 0.483 0.456 0.439
32 kVp 0.582 0.551 0.531 0.505 0.481
35 kVp 0.619 0.597 0.569 0.545 0.523
38 kVp 0.645 0.627 0.602 0.574 0.556
3 cm thick
26 kVp 0.427 0.395 0.363 0.337 0.310
29 kVp 0.440 0.409 0.382 0.353 0.329
32 kVp 0.489 0.457 0.427 0.399 0.371
35 kVp 0.528 0.494 0.464 0.438 0.410
38 kVp 0.563 0.531 0.502 0.474 0.446
4 cm thick
26 kVp 0.355 0.321 0.290 0.265 0.243
29 kVp 0.371 0.339 0.309 0.284 0.259
32 kVp 0.419 0.384 0.352 0.326 0.301
35 kVp 0.458 0.423 0.393 0.365 0.337
38 kVp 0.494 0.458 0.428 0.399 0.371
5 cm thick
26 kVp 0.301 0.271 0.242 0.217 0.197
29 kVp 0.320 0.290 0.260 0.236 0.213
32 kVp 0.358 0.329 0.297 0.270 0.247
35 kVp 0.398 0.366 0.334 0.306 0.282
38 kVp 0.432 0.399 0.368 0.339 0.313
6 cm thick
26 kVp 0.259 0.229 0.203 0.181 0.163
29 kVp 0.276 0.247 0.221 0.199 0.179
32 kVp 0.319 0.287 0.260 0.234 0.212
35 kVp 0.356 0.323 0.294 0.268 0.244
38 kVp 0.388 0.350 0.323 0.295 0.272
7 cm thick
26 kVp 0.225 0.197 0.175 0.156 0.138
29 kVp 0.244 0.215 0.193 0.172 0.155
32 kVp 0.279 0.250 0.224 0.200 0.183
35 kVp 0.317 0.286 0.260 0.233 0.214
38 kVp 0.345 0.314 0.283 0.259 0.236
8 cm thick
26 kVp 0.200 0.174 0.153 0.137 0.121
29 kVp 0.215 0.193 0.169 0.151 0.136
32 kVp 0.252 0.225 0.200 0.181 0.163
35 kVp 0.286 0.257 0.231 0.208 0.190
38 kVp 0.312 0.284 0.256 0.233 0.212
9 cm thick
26 kVp 0.178 0.156 0.137 0.121 0.108
29 kVp 0.194 0.171 0.151 0.135 0.121
32 kVp 0.228 0.203 0.181 0.161 0.144
35 kVp 0.260 0.233 0.209 0.188 0.170
38 kVp 0.285 0.257 0.233 0.210 0.191
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See Table IX in the Appendix.
Medical Physics, Vol. 41, No. 9, September 2014
091501-10 Sechopoulos et al.: Breast Tomosynthesis Radiation Dosimetry: Task Group 223 Report 091501-10
TABLE IX. RGD and RGD values for the Hologic Selenia Dimensions tomosynthesis system when used in the wide angular range mode (±15◦).
Angle (deg)
Thickness (cm) 0.00 1.07 2.14 3.21 4.29 5.36 6.43 7.50 8.57 9.64 10.71 11.79 12.86 13.93 15.00 RGD
2 1.000 1.001 1.000 0.998 0.997 0.997 0.996 0.993 0.992 0.990 0.987 0.983 0.980 0.978 0.975 0.991
3 1.000 1.002 0.999 1.000 0.998 0.997 0.995 0.992 0.991 0.988 0.984 0.981 0.978 0.971 0.967 0.989
4 1.000 0.998 0.999 0.997 0.996 0.994 0.992 0.989 0.987 0.984 0.981 0.976 0.971 0.967 0.962 0.986
5 1.000 1.000 0.999 0.996 0.996 0.994 0.991 0.989 0.985 0.982 0.978 0.973 0.969 0.962 0.957 0.985
6 1.000 0.999 0.998 0.997 0.996 0.993 0.991 0.988 0.984 0.979 0.975 0.971 0.965 0.960 0.953 0.983
7 1.000 1.000 1.000 0.998 0.996 0.994 0.991 0.987 0.984 0.979 0.974 0.969 0.964 0.957 0.951 0.983
8 1.000 1.001 0.998 0.998 0.996 0.993 0.991 0.986 0.982 0.977 0.972 0.966 0.960 0.954 0.948 0.981
9 1.000 1.000 0.999 0.997 0.996 0.993 0.989 0.984 0.979 0.975 0.969 0.965 0.958 0.951 0.945 0.980
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